stockportfolio.pro
Balchem Corporation (BCPC)
Basic Materials · Specialty Chemicals · NasdaqGS
Balchem Corporation revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $553.20M | $594.79M | $643.68M | $643.71M | $703.64M | $799.02M | $942.36M | $922.44M | $953.68M | $1.04B |
| Gross profit | $180.86M | $189.01M | $204.25M | $211.37M | $223.90M | $243.17M | $280.45M | $302.06M | $336.21M | $370.63M |
| Net income | $55.97M | $90.07M | $78.57M | $79.67M | $84.62M | $96.10M | $105.37M | $108.54M | $128.47M | $154.84M |
| Net margin | 10.1% | 15.1% | 12.2% | 12.4% | 12.0% | 12.0% | 11.2% | 11.8% | 13.5% | 14.9% |
Source: Balchem Corporation SEC filings (10-K). 17 years of history available in the interactive view.
Explore 17 years of Balchem Corporation financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track BCPC in your portfolio →
About Balchem Corporation
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Balchem Corporation — frequently asked questions
What is Balchem Corporation's revenue?
Balchem Corporation (BCPC) reported revenue of $1.04B for fiscal year 2025, up 8.8% from the prior year, according to its SEC filings.
Is Balchem Corporation profitable?
Yes. BCPC earned net income of $154.84M in fiscal 2025, a net margin of 14.9%.
What is BCPC's P/E ratio?
Balchem Corporation trades at a price-to-earnings ratio of about 33.0 based on the latest data in our nightly-refreshed cache.
How fast is Balchem Corporation growing?
BCPC's revenue grew at roughly 8.1% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
Where does this data come from?
All figures are computed from Balchem Corporation's official SEC filings (10-K and 10-Q), covering 17 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.